Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report ...
Quest Diagnostics (NYSE:DGX) is partnering with Guardant Health to offer Shield, an FDA-approved blood test for colorectal ...
Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...
Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify ...
Gardner and Wallace will be based in Quest’s Secaucus headquarters, a company representative told NJBIZ. “These latest appointments continue to strengthen Quest’s leadership team and position us well ...
New Jersey-based Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic information services, offering a ...
Zacks Investment Research on MSN
Quest Diagnostics (DGX) down 4.2% since last earnings report: Can it rebound?
A month has gone by since the last earnings report for Quest Diagnostics (DGX). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that its board of directors ...
Quest Diagnostics is a dominant player in the growing medical testing industry, offering consistent earnings and dividend growth with lower volatility. DGX benefits from secular tailwinds like aging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results